Long-term disease control by trabectedin in a patient with dedifferentiated liposarcoma: A case report

RATIONALE: Trabectedin is an antitumor drug considered to be effective for liposarcoma, leiomyosarcoma, and translocation-related sarcoma. Concerning liposarcoma subtypes, evidence of the efficacy of trabectedin for dedifferentiated liposarcoma (DDLPS) is poor, whereas it is known to have high effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Shogo, Tanaka, Kazuhiro, Kawano, Masanori, Iwasaki, Tatsuya, Itonaga, Ichiro, Tsumura, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959950/
https://www.ncbi.nlm.nih.gov/pubmed/31914068
http://dx.doi.org/10.1097/MD.0000000000018689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959950/
https://www.ncbi.nlm.nih.gov/pubmed/31914068
http://dx.doi.org/10.1097/MD.0000000000018689

Ejemplares similares